4/A: Allurion Technologies Chief Legal Officer Receives Stock Option Grant

Brendan M. Gibbons, Chief Legal Officer of Allurion Technologies, received a stock option grant for 253,807 shares, as detailed in an amended SEC Form 4/A filing.

Summary

• This is an amended SEC Form 4/A filing regarding a change in beneficial ownership for Brendan M. Gibbons, Chief Legal Officer of Allurion Technologies, Inc.
• The amendment corrects the number of shares underlying a stock option granted to Gibbons.
• On February 8, 2024, Gibbons received a stock option for 253,807 shares of Allurion Technologies common stock at an exercise price of $2.96.
• The option vests over time, with 25% vesting on January 29, 2025, and the remainder vesting in 36 equal monthly installments, contingent upon continued service.

Sentiment

Score: 6

Explanation: The document is a routine disclosure of executive compensation. It's neutral in sentiment, reflecting standard corporate governance practices.

Positives

• The grant of stock options to a key executive aligns their interests with those of the shareholders.
• The vesting schedule encourages continued service and commitment from the Chief Legal Officer.

Future Outlook

The vesting schedule of the stock options suggests an expectation of continued service from the Chief Legal Officer.

Industry Context

Stock option grants are a common form of executive compensation in the technology industry, used to attract and retain talent and align their interests with company performance.

Comparison to Industry Standards

• Stock option grants are a standard component of executive compensation packages in publicly traded companies, particularly in the technology and healthcare sectors.
• Companies like Medtronic and Boston Scientific also use stock options as part of their executive compensation plans.
• The vesting schedule is typical, with a combination of cliff vesting (25% after one year) and subsequent monthly vesting.

Stakeholder Impact

• Shareholders may view the stock option grant as a positive incentive for the Chief Legal Officer to contribute to the company's success.
• Employees may see the grant as a sign of the company's commitment to its leadership team.

Key Dates